A detailed history of Sei Investments CO transactions in Haemonetics Corp stock. As of the latest transaction made, Sei Investments CO holds 134,428 shares of HAE stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
134,428
Previous 132,474 1.48%
Holding current value
$10.6 Million
Previous $11 Million 1.42%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.45 - $91.58 $141,567 - $178,947
1,954 Added 1.48%
134,428 $10.8 Million
Q2 2024

Aug 13, 2024

BUY
$81.24 - $97.37 $730,103 - $875,064
8,987 Added 7.28%
132,474 $11 Million
Q1 2024

May 07, 2024

SELL
$71.24 - $85.35 $280,614 - $336,193
-3,939 Reduced 3.09%
123,487 $10.5 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $249,990 - $287,276
-3,102 Reduced 2.38%
127,426 $10.9 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $660,314 - $747,733
7,998 Added 6.53%
130,528 $11.7 Million
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $565,718 - $625,971
6,998 Added 6.06%
122,530 $10.4 Million
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $169,653 - $211,279
2,332 Added 2.06%
115,532 $9.56 Million
Q4 2022

Feb 10, 2023

BUY
$73.85 - $86.14 $801,641 - $935,049
10,855 Added 10.61%
113,200 $8.9 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $153,439 - $190,671
2,424 Added 2.43%
102,345 $7.58 Million
Q2 2022

Aug 15, 2022

BUY
$49.27 - $66.08 $904,843 - $1.21 Million
18,365 Added 22.52%
99,921 $6.53 Million
Q1 2022

May 13, 2022

BUY
$43.77 - $63.22 $82,243 - $118,790
1,879 Added 2.36%
81,556 $5.18 Million
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $35,676 - $53,704
720 Added 0.91%
79,677 $4.22 Million
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $149,011 - $182,616
2,587 Added 3.39%
78,957 $5.57 Million
Q2 2021

Aug 06, 2021

BUY
$51.81 - $118.56 $1.01 Million - $2.32 Million
19,589 Added 34.5%
76,370 $5.08 Million
Q1 2021

May 12, 2021

BUY
$111.01 - $139.48 $26,642 - $33,475
240 Added 0.42%
56,781 $6.33 Million
Q4 2020

Feb 08, 2021

SELL
$88.75 - $119.95 $503,301 - $680,236
-5,671 Reduced 9.12%
56,541 $6.71 Million
Q3 2020

Dec 04, 2020

SELL
$75.65 - $93.58 $2,269 - $2,807
-30 Reduced 0.05%
62,212 $5.43 Million
Q3 2020

Nov 06, 2020

SELL
$75.65 - $93.58 $16.3 Million - $20.1 Million
-214,938 Reduced 77.54%
62,242 $5.43 Million
Q2 2020

Aug 17, 2020

BUY
$84.96 - $118.91 $6.55 Million - $9.17 Million
77,104 Added 38.54%
277,180 $24.8 Million
Q2 2020

Aug 11, 2020

BUY
$84.96 - $118.91 $402,795 - $563,752
4,741 Added 2.43%
200,076 $22.8 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $167,934 - $275,191
2,259 Added 1.17%
195,335 $19.5 Million
Q4 2019

Feb 06, 2020

SELL
$114.37 - $129.46 $432,432 - $489,488
-3,781 Reduced 1.92%
193,076 $22.2 Million
Q3 2019

Nov 12, 2019

SELL
$117.16 - $138.52 $3.1 Million - $3.66 Million
-26,417 Reduced 11.83%
196,857 $24.8 Million
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $4.41 Million - $6.49 Million
53,925 Added 31.84%
223,274 $26.9 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $3.09 Million - $3.79 Million
37,106 Added 28.06%
169,349 $14.8 Million
Q4 2018

Feb 13, 2019

BUY
$90.66 - $116.63 $1.61 Million - $2.07 Million
17,730 Added 15.48%
132,243 $14.9 Million
Q3 2018

Nov 08, 2018

SELL
$89.96 - $114.58 $1.56 Million - $1.99 Million
-17,337 Reduced 13.15%
114,513 $13.1 Million
Q2 2018

Aug 03, 2018

BUY
$71.53 - $95.75 $8.46 Million - $11.3 Million
118,305 Added 873.42%
131,850 $11.8 Million
Q1 2018

May 11, 2018

BUY
$60.72 - $74.41 $188,414 - $230,894
3,103 Added 29.72%
13,545 $990,000
Q4 2017

Feb 08, 2018

BUY
$44.96 - $58.99 $350,058 - $459,296
7,786 Added 293.15%
10,442 $606,000
Q3 2017

Nov 06, 2017

BUY
$40.38 - $44.87 $107,249 - $119,174
2,656
2,656 $119,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.05B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.